FACET BIOTECH CORP (FACT)

Overview Price 0.00 Price Change Today 0.00 (0.00%) P&P rating Open Price $6.84 Previous Close $0.00 Daily Range 52-Week Range Volume 0 Other Resources for FACT Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Concur Joins Cloud Network May 12, 2011 NetSuite, Inc. is the leading provider of on-demand, integrated business management software for growing and midsize businesses. With thousands of customers globally using NetSuite's online products and professional services, companies are enabled to manage all key business operations in a single hosted system, including: customer relationship management; order fulfillment; inventory; accounting and finance, product assembly; ecommerce; Web site management; and employee productivity.   Brokerage Analyst Recommendations 20 Brokerage Firms Covering N   Strong Buy 4 Buy 2 Hold 13 Sell 0 Strong Sell 1 Average Broker Recommendation (ABR): 2.55   N Ratings: BUY  SELL  HOLD N Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 2 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
zantriocom	0.00	09/08/09	Zantrio.com Stock Picks for September 8, 2009	0
Zacks_Analysts	0.00	04/09/10	Abbott a Step Closer to FACT - Analyst Blog	0
Zacks_Analysts	0.00	03/23/10	Abbott Completes Starlims Buyout - Analyst Blog	0
Zacks_Analysts	0.00	03/22/10	Trubion Loss Wider Than Expected - Analyst Blog	0
Zacks_Analysts	0.00	03/10/10	Abbott on Acquisition Spree - Analyst Blog	0
Zacks_Analysts	0.00	12/24/09	Moody's Downgrades Celanese - Analyst Blog	0
Zacks_Analysts	0.00	12/11/09	Facet Rejects Biogen Again - Analyst Blog	0
Zacks_Analysts	0.00	10/20/09	Biogen Reports Higher Earnings - Analyst Blog	0
Zacks_Analysts	0.00	10/20/09	Zacks Analyst Blog Highlights: Biogen Idec Inc., Facet Biotech Corporation, Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics - Press Releases	0
Zacks_Analysts	0.00	10/19/09	Biogen Extends Hostile Bid - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: FACET BIOTECH CORP (FACT) Start Price: $16.15 Points: -131.63 Created: 09/07/2009 Comments: 0 | Comment JJONES Recs:

BUY: FACET BIOTECH CORP (FACT) Start Price: $9.49 Points: -149.43 Created: 01/04/2009 Comments: 0 | Comment JustSayNo Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
JJONES	99.63	BUY	Week or Less	09/07/2009	$16.15		-100.00%	+31.63%	-131.63
JustSayNo	73.20	BUY	One to Three Months	01/04/2009	$9.49		-100.00%	+49.43%	-149.43